Clinical Orthopaedics and Related Research®

, Volume 470, Issue 2, pp 351–356 | Cite as

The Frank Stinchfield Award: Dislocation in Revision THA: Do Large Heads (36 and 40 mm) Result in Reduced Dislocation Rates in a Randomized Clinical Trial?

  • Donald S. Garbuz
  • Bassam A. Masri
  • Clive P. Duncan
  • Nelson V. Greidanus
  • Eric R. Bohm
  • Martin J. Petrak
  • Craig J. Della Valle
  • Allan E. Gross
Symposium: Papers Presented at the Annual Meetings of The Hip Society



Dislocation after revision THA is a common complication. Large heads have the potential to decrease dislocation rate, but it is unclear whether they do so in revision THA.


We therefore determined whether a large femoral head (36 and 40 mm) resulted in a decreased dislocation rate compared to a standard head (32 mm).


We randomized 184 patients undergoing revision THA to receive either a 32-mm head (92 patients) or 36- and 40-mm head (92 patients) and stratified patients by surgeon. The two groups had similar baseline demographics. The primary end point was dislocation. Quality-of-life (QOL) measures were WOMAC and SF-36. The mean followup for dislocation was 5 years (range, 2–7 years); the mean followup for QOL was 2.2 years (range, 1.6–4 years).


In the 36- and 40-mm head group, the dislocation rate was 1.1% (one of 92) versus 8.7% (eight of 92) for the 32-mm head. There was no difference in QOL outcomes between the two groups.


Our observations confirm a large femoral head (36 or 40 mm) reduces dislocation rates in patients undergoing revision THA at short-term followup. We now routinely use large heads with a highly crosslinked polyethylene acetabular liner in all revision THAs.

Level of Evidence

Level I, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.



The authors thank the following for recruiting patients: Dr. David Backstein, MD, MED, FRCSC, at Mount Sinai Hospital in Toronto, Canada; Dr. Colin Burnell, MD, FRCSC, Dr. David Hedden MD, FRCSC, and Dr. Thomas Turgeon, MD, MPH, FRCSC, at the University of Manitoba in Winnipeg, Canada; Dr. Scott Sporer, MD, at Rush University Medical Center in Chicago, IL, USA; Dr. Steven H. Weeden, MD, at the Texas Hip & Knee Center in Fort Worth, TX, USA; Dr. Paul Kim, MD, FRCSC, at the University of Ottawa, Canada; and Dr. Michael J. Dunbar, MD, PhD, FRCPC, at Dalhousie University in Halifax, Canada. The authors also thank Lorna McLean, Daphné Savoy, Matthew MacDonald, Sarah Tran, Emily Dittle, Carly Valdez, Heather Belanger, and Sue Moore for patient recruitment and study coordination and Eric Sayre, PhD, for his help with the statistical analysis.


  1. 1.
    Alberton GM, High WA, Morrey BF. Dislocation after revision total hip arthroplasty: an analysis of risk factors and treatment options. J Bone Joint Surg Am. 2002;84:1788–1792.PubMedGoogle Scholar
  2. 2.
    American Academy of Orthopaedic Surgeons. The burden of musculoskeletal diseases in the United States. Rosemont, IL. 2008. Available at: Accessed November 2, 2010.
  3. 3.
    Amlie E, Høvik Ø, Reikerås O. Dislocation after total hip arthroplasty with 28 and 32-mm femoral head. J Orthop Traumatol. 2010;11:111–115.PubMedCrossRefGoogle Scholar
  4. 4.
    Bartz RL, Nobel PC, Kadakia NR, Tullos HS. The effect of femoral component head size on posterior dislocation of the artificial hip joint. J Bone Joint Surg Am. 2000;82:1300–1307.PubMedGoogle Scholar
  5. 5.
    Bellamy N, Buchanan W, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or the knee. J Rheumatol. 1988;15:1833–1840.PubMedGoogle Scholar
  6. 6.
    Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis: consensus development at OMERACT III. J Rheumatol. 1997;24:799–802.PubMedGoogle Scholar
  7. 7.
    Berry DJ, von Knoch M, Schleck CD, Harmsen WS. Effect of femoral head diameter and operative approach on risk of dislocation after primary total hip arthroplasty. J Bone Joint Surg Am. 2005;87:2456–2463.PubMedCrossRefGoogle Scholar
  8. 8.
    Burroughs BR, Hallstrom B, Golladay GJ, Hoeffel D, Harris WH. Range of motion and stability in total hip arthroplasty with 28-, 32-, 38-, and 44-mm femoral head sizes. J Arthroplasty. 2005;20:11–19.PubMedCrossRefGoogle Scholar
  9. 9.
    Burroughs BR, Rubash HE, Harris WH. Femoral head sizes larger than 32 mm against highly cross-linked polyethylene. Clin Orthop Relat Res. 2002;405:150–157.PubMedCrossRefGoogle Scholar
  10. 10.
    Conroy JL, Whitehouse SL, Graves SE, Pratt NL, Ryan P, Crawford RW. Risk factors for revision for early dislocation in total hip arthroplasty. J Arthroplasty. 2008;23:867–872.PubMedCrossRefGoogle Scholar
  11. 11.
    Crowninshield RD, Maloney WJ, Wentz DH, Humphrey SM, Blanchard CR. Biomechanics of large femoral heads: what they do and don’t do. Clin Orthop Relat Res. 2004;429:102–107.PubMedCrossRefGoogle Scholar
  12. 12.
    Dudda M, Gueleryuez A, Gautier E, Busato A, Roeder C. Risk factors for early dislocation after total hip arthroplasty: a matched case-control study. J Orthop Surg (Hong Kong). 2010;18:179–183.Google Scholar
  13. 13.
    Geller JA, Malchau H, Bragdon C, Greene M, Harris WH, Freiberg AA. Large diameter femoral heads on highly cross-linked polyethylene: minimum 3-year results. Clin Orthop Relat Res. 2006;447:53–59.PubMedCrossRefGoogle Scholar
  14. 14.
    Jameson SS, Lees D, James P, Serrano-Pedraza I, Partington PF, Muller SD, Meek RM, Reed MR. Lower rates of dislocation with increased femoral head size after primary total hip replacement: a five-year analysis of NHS patients in England. J Bone Joint Surg Br. 2011;93:876–880.PubMedCrossRefGoogle Scholar
  15. 15.
    Jenkinson C, Wright L, Coulter A. Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res. 1994;3:7–12.PubMedCrossRefGoogle Scholar
  16. 16.
    Kelley SS, Lachiewicz PF, Hickman JM, Paterno SM. Relationship of femoral head and acetabular size to the prevalence of dislocation. Clin Orthop Relat Res. 1998;355:163–170.PubMedCrossRefGoogle Scholar
  17. 17.
    Kiguchi K, Horie T, Yamashita A, Ueno M, Kobayashi T, Mawatari M, Hotokebuchi T. A study of the effect of the femoral head diameter on prosthetic hip joint dislocation using a hip-joint motion simulator. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:6058–6061.PubMedGoogle Scholar
  18. 18.
    Kung PL, Ries MD. Effect of femoral head size and abductors on dislocation after revision THA. Clin Orthop Relat Res. 2007;465:170–174.PubMedGoogle Scholar
  19. 19.
    Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.PubMedCrossRefGoogle Scholar
  20. 20.
    Lachiewicz PF, Soileau ES. Dislocation of primary total hip arthroplasty with 36 and 40-mm femoral heads. Clin Orthop Relat Res. 2006;453:153–155.PubMedCrossRefGoogle Scholar
  21. 21.
    Morrey BF. Instability after total hip arthroplasty. Orthop Clin North Am. 1992;23:237–248.PubMedGoogle Scholar
  22. 22.
    Scifert CF, Brown TD, Pedersen DR, Callaghan JJ. A finite element analysis of factors influencing total hip dislocation. Clin Orthop Relat Res. 1998;355:152–162.PubMedCrossRefGoogle Scholar
  23. 23.
    Skeels MD, Berend KR, Lombardi AV Jr. The dislocator, early and late: the role of large heads. Orthopedics. 2009;32:667. pii: = 42837. doi:10.3928/01477447-20090728-14.Google Scholar
  24. 24.
    Springer BD, Fehring TK, Griffin WL, Odum SM, Masonis JL. Why revision total hip arthroplasty fails. Clin Orthop Relat Res. 2009;467:166–173.PubMedCrossRefGoogle Scholar
  25. 25.
    Yuan L, Shih C. Dislocation after total hip arthroplasty. Arch Orthop Trauma Surg. 1999;119:263–266.PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2011

Authors and Affiliations

  • Donald S. Garbuz
    • 1
  • Bassam A. Masri
    • 1
  • Clive P. Duncan
    • 1
  • Nelson V. Greidanus
    • 1
  • Eric R. Bohm
    • 2
  • Martin J. Petrak
    • 2
  • Craig J. Della Valle
    • 3
  • Allan E. Gross
    • 4
  1. 1.Department of OrthopaedicsUniversity of British ColumbiaVancouverCanada
  2. 2.University of Manitoba Joint Replacement Group, Concordia HospitalWinnipegCanada
  3. 3.Department of Orthopaedic SurgeryRush University Medical CenterChicagoUSA
  4. 4.Division of Orthopaedic SurgeryMount Sinai HospitalTorontoCanada

Personalised recommendations